About Binge Eating Disorder
Binge Eating Disorder (BED), was assigned its own category of eating disorder by the American Psychiatric Association (APA). They define BED as “recurring episodes of eating significantly more food in a short period of time than most people would eat under similar circumstances” and state that: “While overeating is a challenge for many Americans, recurrent binge eating is much less common, far more severe, and is associated with significant physical and psychological problems.” BED is the most common eating disorder, affecting 8 million people in the U.S., as reported by The National Association of Anorexia Nervosa and Associated Disorders (ANAD).
ANAD states that for patients with BED, the sight or smell of food increases dopamine levels, activating the brain’s reward circuitry. This may prompt episodes of compulsive overeating. Opiant’s opioid antagonist nasal spray could be used as a symptom-driven therapy to manage activation of the reward circuitry, and help patients control their bingeing behavior.